Connecticut startup CyVek has nailed down $3 million in new funding toward the development of a test system designed to handle molecular diagnostics, immunodiagnostics and bioassays for both drug discovery and clinical care use, MassHighTech is reporting. CyVek, which launched in 2010, disclosed the funding in a federal filing. The company raised $4 million in a Series B round almost two years ago, according to the article, including $802,000 from Connecticut Innovations. Story